Home > Healthcare > Medical Devices > Diagnostic Devices > Fertility Testing Devices Market
Male fertility kits segment captured more than 11% of the market share in 2020 led by the increasing infertility issues in men worldwide. For instance, according to the Lancet report published in 2020, nearly 8-12% of couples globally are facing problem of infertility, with the males being primary cause in around 50% of couples. The causes of male infertility are many. It may be due to any physical abnormality, it may be acquired, or it could be an idiopathic factor. For instance, it has been reported that around 15% of men suffer with infertility, though they have normal semen and normal sperm count. Thus, fertility testing device manufacturers are coming up with specialized male fertility kits, such as anti-sperm antibody SFT kit, semen pH kit, and different morphology kits to detect all the possibilities that contributes to infertility in men.
Over the counter (OTC) segment in the fertility testing devices market was valued at over USD 460 million in 2020 owing to the increasing availability of home-based kits, increasing prescription cost, and effective regulation of OTC products by government bodies to ensure effectiveness of product as well as safety of consumer.
Female segment is poised to showcase 6.3% growth rate through 2027. This is mainly attributed to recurrent usage of ovulation kits and increasing cases of infertility in women. According to global burden of disease study conducted in 2017, the prevalence rate of female infertility increased from 1,366.85 per 100,000 in 1990 to 1,571.35 per 100,000 in 2017 showing an increase of 0.37% per year.
The home care setting segment captured USD 315 million in 2020. The segment growth is credited to the availability of testing devices, that can be used without the help of professionals. For instance, the Mira fertility plus system is almost like having a mini fertility lab at home which predicts ovulation with accurate LH and E3G concentrations. Such fertility testing devices does not require any professional help for its use. Another fertility device by Ava Science Inc, is bracelet that helps in detecting 5.3 fertile days in each cycle by monitoring body temperature, resting pulse rate, heart rate, and sleep. Therefore, leverage of tracking one’s cycles at home without paying regular visits to fertility clinics is slated to propel the segment expansion during the forecast period.
North America fertility testing devices market held over 36% of revenue share in 2020 on account of the lifestyle changes leading to infertility disorders. For instance, according to CDC report, the general fertility rate in U.S. in 2020 was 56 births per 1000 woman. It was nearly a half of what it was in 1960’s. Besides infertility issues, increasing adolescent pregnancy in the region is also driving the industry expansion.